Cargando…

Humoral immune response to SARS-CoV-2 mRNA vaccines is associated with choice of vaccine and systemic adverse reactions

PURPOSE: Although the fast development of safe and effective messenger RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 has been a success, waning humoral immunity has led to the recommendation of booster immunization. However, knowledge of the humoral immune response to d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klingel, Hanna, Krüttgen, Alexander, Imöhl, Matthias, Kleines, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Vaccine Society 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950231/ https://www.ncbi.nlm.nih.gov/pubmed/36844685 http://dx.doi.org/10.7774/cevr.2023.12.1.60

Ejemplares similares

Severity of adverse reactions is associated with T-cell response in mRNA-1273 vaccinated health care workers
por: Klingel, Hanna, et al.
Publicado: (2022)

Evaluation of the QuantiFERON SARS-CoV-2 interferon-ɣ release assay in mRNA-1273 vaccinated health care workers
por: Krüttgen, Alexander, et al.
Publicado: (2021)

Two novel SARS-CoV-2 surrogate virus neutralization assays are suitable for assessing successful immunization with mRNA-1273
por: Krüttgen, Alexander, et al.
Publicado: (2022)

Large inter-individual variability of cellular and humoral immunological responses to mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in health care workers
por: Krüttgen, Alexander, et al.
Publicado: (2022)

Comparison of the SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit
por: Krüttgen, Alexander, et al.
Publicado: (2021)

Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG
por: Krüttgen, Alexander, et al.
Publicado: (2020)

Determination of SARS-CoV-2 antibodies with assays from Diasorin, Roche and IDvet
por: Krüttgen, Alexander, et al.
Publicado: (2021)

Reply to the letter from Dr. Nikolayevskyy et al. referring to our publication published in the Journal of Virological Methods 298 (2021)11:4295 “Evaluation of the QuantiFERON SARS-CoV-2 Interferon-ɣ release assay in mRNA-1273 vaccinated health care workers”
por: Krüttgen, Alexander, et al.
Publicado: (2022)

Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease
por: Bitzenhofer, Michaela, et al.
Publicado: (2022)

Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered
por: López-Cortés, Luis F., et al.
Publicado: (2023)

Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer
por: Mairhofer, Mario, et al.
Publicado: (2021)

SARS-CoV-2 mRNA Vaccine-Induced Cellular and Humoral Immunity in Hemodialysis Patients
por: Kwiatkowska, Ewa, et al.
Publicado: (2022)

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis
por: Strengert, Monika, et al.
Publicado: (2021)

Intensity of Humoral Immune Responses, Adverse Reactions, and Post-Vaccination Morbidity after Adenovirus Vector-Based and mRNA Anti-COVID-19 Vaccines
por: Voulgaridi, Ioanna, et al.
Publicado: (2022)

Humoral responses to SARS-CoV-2 mRNA vaccines: Role of past infection
por: Gray, Ashley N., et al.
Publicado: (2021)

Longitudinal SARS-CoV-2 mRNA Vaccine-Induced Humoral Immune Responses in Patients with Cancer
por: Figueiredo, Jane C., et al.
Publicado: (2021)

SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity
por: Jaycox, Jillian R., et al.
Publicado: (2023)

Humoral Immune Response Following SARS-CoV-2 mRNA Vaccination and Infection in Pediatric-Onset Multiple Sclerosis
por: Breu, Markus, et al.
Publicado: (2023)

Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients
por: Oyaert, Matthijs, et al.
Publicado: (2022)

Humoral response of the mRNA-1273 SARS-CoV-2 vaccine in peritoneal dialysis patients
por: Rodríguez-Espinosa, Diana, et al.
Publicado: (2021)

Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccination
por: Nziza, Nadège, et al.
Publicado: (2023)

Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV
por: Marchitto, Lorie, et al.
Publicado: (2023)

Study of humoral and cellular immunity in vaccinated with mRNA‐1273
por: Gutiérrez‐Bautista, Juan Francisco, et al.
Publicado: (2022)

Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals
por: Fraley, Elizabeth, et al.
Publicado: (2021)

HLA Class II Polymorphism and Humoral Immunity Induced by the SARS-CoV-2 mRNA-1273 Vaccine
por: Gutiérrez-Bautista, Juan Francisco, et al.
Publicado: (2022)

SARS-CoV-2 Infection-and mRNA Vaccine-induced Humoral Immunity among Schoolchildren in Hawassa, Ethiopia
por: Merid, Yared, et al.
Publicado: (2023)

Immediate reactions after mRNA SARS-CoV-2 vaccination
por: Jeimy, Samira, et al.
Publicado: (2021)

Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab
por: Capuano, Rocco, et al.
Publicado: (2021)

Humoral Responses After SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer Patients
por: Chumsri, Saranya, et al.
Publicado: (2021)

Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies
por: Jiménez, Moraima, et al.
Publicado: (2022)

Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients: (Response to: Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.)
por: Hasmann, Sandra, et al.
Publicado: (2021)

Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2
por: Vollenberg, Richard, et al.
Publicado: (2022)

Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab
por: Bacova, Barbora, et al.
Publicado: (2022)

Humoral and cellular immune responses to the mRNA-1273 SARS-CoV-2 vaccine booster in patients on maintenance dialysis
por: Karakizlis, Hristos, et al.
Publicado: (2022)

Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2022)

Hybrid immunity expands the functional humoral footprint of both mRNA and vector-based SARS-CoV-2 vaccines
por: Kaplonek, Paulina, et al.
Publicado: (2023)

Adverse cutaneous reactions after mRNA SARS-CoV-2 vaccination in 3 patients: a spectrum of severity
por: Edgerley, Sarah, et al.
Publicado: (2022)

Safety of SARS-CoV-2 mRNA vaccines and effects of immunosuppressive drugs on adverse reactions in patients with rheumatic diseases
por: Kawazoe, Mai, et al.
Publicado: (2023)

Cellular and Humoral Responses Follow-up for 8 Months after Vaccination with mRNA-Based Anti-SARS-CoV-2 Vaccines
por: Gil-Manso, Sergio, et al.
Publicado: (2022)

Anti‐SARS‐CoV‐2 mRNA vaccines as inducers of humoral response against apolipoprotein A‐1?
por: Vuilleumier, Nicolas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2l3r6tbtsgqgofdfbt4u7cbpen